BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25368922)

  • 1. Screening for cancer: concepts and controversies.
    Gates TJ
    Am Fam Physician; 2014 Nov; 90(9):625-31. PubMed ID: 25368922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Cancer Society Changes Breast Cancer Screening Guidelines To Reflect Analysis of Benefits and Harms.
    Fenichel M
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26864931
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for cancer: advice for high-value care from the American College of Physicians.
    Wilt TJ; Harris RP; Qaseem A;
    Ann Intern Med; 2015 May; 162(10):718-25. PubMed ID: 25984847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for cancer: evaluating the evidence.
    Gates TJ
    Am Fam Physician; 2001 Feb; 63(3):513-22. PubMed ID: 11272300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
    Mortani Barbosa EJ
    Acad Radiol; 2015 Aug; 22(8):976-82. PubMed ID: 25772581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer: a guidance statement from the American College of Physicians.
    Qaseem A; Denberg TD; Hopkins RH; Humphrey LL; Levine J; Sweet DE; Shekelle P;
    Ann Intern Med; 2012 Mar; 156(5):378-86. PubMed ID: 22393133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Cancer: Screening and Evaluation of Patients With Solitary Pulmonary Nodules.
    Mott TF
    FP Essent; 2018 Jan; 464():17-22. PubMed ID: 29313653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial results did not resolve controversies surrounding prostate cancer screening.
    Hoffman RM
    Curr Opin Urol; 2010 May; 20(3):189-93. PubMed ID: 20224414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating efficacy of current lung cancer screening guidelines.
    Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
    J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
    Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
    Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thinking beyond the treatment effect in screening for lung cancer.
    Jha S
    Acad Radiol; 2015 Aug; 22(8):983-4. PubMed ID: 26100199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer screening with low-dose CT (LDCT), or when a public health intervention is beyond the patient's benefit.
    Ruano-Ravina A; Heleno B; Fernández-Villar A
    J Epidemiol Community Health; 2015 Feb; 69(2):99-100. PubMed ID: 25138391
    [No Abstract]   [Full Text] [Related]  

  • 15. United States Preventive Services Task Force screening mammography recommendations: science ignored.
    Hendrick RE; Helvie MA
    AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis.
    Ebell MH; Bentivegna M; Hulme C
    Ann Fam Med; 2020 Nov; 18(6):545-552. PubMed ID: 33168683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current controversies in screening: cholesterol, breast cancer, and prostate cancer.
    Sox HC
    Mt Sinai J Med; 1999 Mar; 66(2):91-101. PubMed ID: 10100412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening: did we really need a randomized controlled trial?
    Al-Ayoubi AM; Flores RM
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):29-33. PubMed ID: 27005972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection for lung cancer. New tools for casefinding.
    Lam S; Lam B; Petty TL
    Can Fam Physician; 2001 Mar; 47():537-44. PubMed ID: 11281087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.